嗜铬细胞瘤与副神经节瘤中血浆儿茶酚胺、体重和糖尿病的相关性
该回顾性队列研究(1999-2020年,360例PCC/PGL患者)评估血浆儿茶酚胺与体重及HbA1c的关系。多变量混合效应模型显示去甲肾上腺素与体重负相关、与HbA1c正相关;术后去甲氧基肾上腺素下降伴随HbA1c改善但体重增加。
要点
- 去甲肾上腺素及其代谢物与HbA1c正相关、与体重负相关
- 术后去甲氧基肾上腺素下降伴HbA1c改善,但体重增加
- 持续儿茶酚胺升高伴体重下降提示转移或复发
核心结论
- 血浆去甲肾上腺素及其代谢物与PCC/PGL患者HbA1c正相关、与体重负相关。
研究设计与样本
- 回顾性队列研究,1999-2020年,纳入360例PCC/PGL患者,中位年龄59岁,56.4%为女性,中位研究时长54.2个月。
主要发现
- 多变量混合效应模型中,去甲肾上腺素与体重负相关(P < 0.0005),去甲氧基肾上腺素与体重负相关(P < 0.0005)。
- 手术队列(n=272)中,术后去甲氧基肾上腺素下降,且与体重负相关(P < 0.0005)。
- 研究终点时去甲肾上腺素或去甲氧基肾上腺素升高(提示转移和/或复发)与体重下降相关。
- 去甲肾上腺素和去甲氧基肾上腺素与HbA1c正相关(P < 0.0005)。
临床怎么用
- 对PCC/PGL患者应关注血浆去甲肾上腺素及去甲氧基肾上腺素水平,其与体重和HbA1c相关。
- 术后去甲氧基肾上腺素下降可能伴随HbA1c改善,但体重可能增加。
- 持续儿茶酚胺升高伴体重下降需警惕转移或复发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Pheochromocytomas and paragangliomas (PCC/PGL) are neuroendocrine tumors with discrete catecholamine profiles that cause incompletely understood metabolic and physiologic changes. OBJECTIVE: The objective was to evaluate relationships between plasma catecholamines, body weight, and hemoglobin A1c (HbA1c). We hypothesized that individual catecholamines would correlate negatively with weight and glucose control. DESIGN: A retrospective cohort study was performed (1999-2020). Wilcoxon rank-sum tests compared nonparametric, continuous variables; mixed-effect linear modeling (MEM) evaluated relationships between catecholamines and weight or HbA1c. The median study duration was 54.2 months [interquartile range (IQR) 19.0-95.1]. SETTING: Tertiary academic hospital. PATIENTS: 360 patients were identified prospectively by referral to our center for management or surveillance of PCC/PGL. The median age was 59 years (IQR 45-67) and 56.4% (n = 203) were female. MAIN OUTCOME MEASURES: The primary and secondary outcomes were weight and HbA1c, respectively. RESULTS: On multivariable MEM, norepinephrine (P < 0.0005) negatively correlated with weight when all catecholamines and their derivatives were tried in the model, and normetanephrine (P < 0.0005) correlated when only metanephrines were included. In the surgical cohort (n = 272), normetanephrine decreased postoperatively and was inversely associated with weight (P < 0.0005). Elevated norepinephrine or normetanephrine at the study termination, indicative of metastatic and/or recurrent disease (MRD), correlated with weight loss. Norepinephrine and normetanephrine (P < 0.0005) directly correlated with HbA1c. CONCLUSION: Plasma norepinephrine and its metabolite directly correlate with HbA1c and inversely correlate with weight in PCC/PGL. After resection, declining normetanephrine levels correlate with improving HbA1c despite an increase in patient body weight. Persistently elevated catecholamines and decreasing weight are observed in MRD.
引用
- Krumeich LN, Cucchiara AJ, Nathanson KL, et al. Correlation Between Plasma Catecholamines, Weight, and Diabetes in Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab. 2021. PMID: 34089611. doi:10.1210/clinem/dgab401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。